SpyGlass Pharma, Inc. Comprehensive Income
SpyGlass Pharma, Inc. (SGP) reported Comprehensive Income of -$19.86 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-08-06
- SpyGlass Pharma, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was -$19.86M.
- SpyGlass Pharma, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$13.82M.
- SpyGlass Pharma, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-06-30 was -$8.68M.
- SpyGlass Pharma, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-03-31 was -$8.82M.
- SpyGlass Pharma, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$39.87M.
- SpyGlass Pharma, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$29.16M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|
| 2026-06-30 | -$19.86M 10-Q · filed 2026-08-06 | -$33.68M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | -$13.82M 10-Q · filed 2026-08-06 | ||
| 2025-12-31 | -$39.87M 10-K · filed 2026-03-26 | ||
| 2025-06-30 | -$8.68M 10-Q · filed 2026-08-06 | -$17.50M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | -$8.82M 10-Q · filed 2026-08-06 | ||
| 2024-12-31 | -$29.16M 10-K · filed 2026-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |